Latest Press Releases
View all
TimeHeadline
26m agoNayax to Report 2026 Q1 Earnings on May 12, 2026
53m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
Precision Biosciences Inc logo

Precision Biosciences Inc

About

Precision Biosciences Inc (NASDAQ:DTIL) — investor relations, events, news, and company updates on 6ix.

Latest News

Yesterday
Precision BioSciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting
Apr 22 2026
Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026
Apr 15 2026
Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries
Apr 8 2026
Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference
Mar 12 2026
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Update

Financials

Revenue
$34.26 M
Market Cap
$170.56 M
EPS
-3.63

Community Chat

Ask AI

6ix6ixAIEvents